Molecular and cellular mechanisms of hexavalent chromium-induced lung cancer: An updated perspective

Current Drug Metabolism

Volumn 13, Issue 3, 2012, Pages 284-305

  Urbano, A M ^a,b,c   Ferreira, L M R ^a,b   Alpoim, M C ^a,c,d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Bronchial; Carcinogenesis; Chromate

Indexed keywords

CARCINOGEN; CHROMIC ACID; CHROMIUM; PROTEIN KINASE; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR;

ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL LINE; CELL METABOLISM; CYTOTOXICITY; DNA BINDING; DNA DAMAGE; DNA REPLICATION; DNA STRAND BREAKAGE; DNA TRANSCRIPTION; ENERGY METABOLISM; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVATION; EPIGENETICS; EXCISION REPAIR; GENE EXPRESSION; GENOMIC INSTABILITY; GENOTOXICITY; HUMAN; IMMUNE SYSTEM; INTRACELLULAR SIGNALING; LUNG CANCER; MISMATCH REPAIR; MUTAGENICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; OXIDATION REDUCTION REACTION; PROTEIN INTERACTION; RNA TRANSCRIPTION; TRANSCRIPTION INITIATION;

ANIMALS; CARCINOGENS, ENVIRONMENTAL; CHROMIUM; ENERGY METABOLISM; ENVIRONMENTAL EXPOSURE; HUMANS; LUNG NEOPLASMS; OCCUPATIONAL EXPOSURE;

EID: 84860535109     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/138920012799320464     Document Type: Article

References (393)

1. Faure, G. Principles and Applications of Inorganic Geochemistry; Maxwell-Macmillan: New York, 1992.
2. Cotton, F. A.; Wilkinson, G.; Murillo, C. A.; Bochmann, M. Advanced Inorganic Chemistry, 6th ed.; John Wiley & Sons, Inc: New York, 1999.
3. Kotaś, J.; Stasicka, Z. Chromium occurrence in the environment and methods of its speciation. Environ. Pollut., 2000, 107, 263-283.
4. Connett, P. H.; Wetterhahn, K. E. Metabolism of the carcinogen chromate by cellular constituents. Struct. Bond, 1983, 54, 93-124.
5. Chinthamreddy, S.; Reddy, K. R. Oxidation and mobility of trivalent chromium in manganese-enriched clays during electrokinetic remediation. J. Soil Contam., 1999, 8, 197-216.
6. IARC (International Agency for Research on Cancer). Chromium, Nickel and Welding (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans); IARC Scientific Publications: Lyon, 1990; Vol. 49.
7. Barceloux, D. G. Chromium. J. Toxicol. Clin. Toxicol., 1999, 37, 173-194.
8. Bianchi, V.; Dal Toso, R.; Debetto, P.; Levis, A. G.; Luciani, S.; Majone, F.; Tamino, G. Mechanisms of chromium toxicity in mammalian cell cultures. Toxicology, 1980, 17, 219-224.
9. Biedermann, K. A.; Landolph, J. R. Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts. Cancer Res., 1987, 47, 3815-3823.
10. Biedermann, K. A; Landolph, J. R. Role of valence state and solubility of chromium compounds on induction of cytotoxicity, mutagenesis, and anchorage independence in diploid human fibroblasts. Cancer Res., 1990, 50, 7835-7842.
11. Mertz, W.; Roginski, E. E.; Swarz, K. Effect of trivalent chromium complexes on glucose uptake by epididymal fat tissue of rats. J. Biol. Chem., 1961, 236, 318-322.
12. Vincent, J. B. Mechanisms of chromium action: low-molecularweight chromium-binding substance. J. Am. Coll. Nutr., 1999, 18, 6-12.
13. Stearns, D. M. Is chromium a trace essential metal? Biofactors, 2000, 11, 149-162.
14. Chen, W. Y.; Chen, C. J.; Liu, C. H.; Mao, F. C. Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice. Diabetes Obes. Metab., 2009, 11, 293-303.
15. Kaats, G. R.; Keith, S. C.; Keith, P. L.; Leckie, R. B.; Perricone, N. V.; Preuss, H. G. A combination of L-arabinose and chromium lowers circulating glucose and insulin levels after an acute oral sucrose challenge. Nutr. J., 2011, 10, 42. [Epub ahead of print]
16. Hexavalent chromium. US Department of Health and Human Services, 1993.
17. Långard, S.; Andersen, A.; Ravnestad, J. Incidence of cancer among ferrochromium and ferrosilicon workers: an extended observation period. Br. J. Ind. Med., 1990, 47, 14-19.
18. Becker, N.; Chang-Claude, J.; Frentzel-Beyme, R. Risk of cancer for arc welders in the Federal Republic of Germany: results of a second follow up (1983-8). Br. J. Ind. Med., 1991, 48, 675-683.
19. De Flora, S. Threshold mechanisms and site specificity in chromium (VI) carcinogenesis. Carcinogenesis, 2000, 21, 533-541.
20. Royle, H. Toxicity of chromic acid in the chromium plating industry (1). Environ. Res., 1975, 10, 39-53.
21. Franchini, I.; Magnani, F.; Mutti, A. Mortality experience among chromeplating workers. Initial findings. Scand. J. Work Environ. Health, 1983, 9, 247-252.
22. Moulin, J. J.; Portefaix, P.; Wild, P.; Mur, J. M.; Smagghe, G.; Mantout, B. Mortality study among workers producing ferroalloys and stainless steel in France. Br. J. Ind. Med., 1990, 47, 537-543.
23. Kusiak, R. A.; Ritchie, A. C.; Muller, J.; Springer, J. Mortality from lung cancer in Ontario uranium miners. Br. J. Ind. Med., 1993, 50, 920-928.
24. Costa, M.; Klein, C. B. Toxicity and carcinogenicity of chromium compounds in humans. Crit. Rev. Toxicol., 2006, 36, 155-163.
25. Gibb, H. J.; Lees, P. S.; Pinsky, P. F.; Rooney, B. C. Lung cancer among workers in chromium chemical production. Am. J. Ind. Med., 2000, 38, 115-126.
26. Park, R. M.; Bena, J. F.; Stayner, L. T.; Smith, R. J.; Gibb, H. J.; Lees, P. S. Hexavalent chromium and lung cancer in the chromate industry: a quantitative risk assessment. Risk Anal., 2004, 24, 1099-1108.
27. Wesseling, C.; Pukkala, E.; Neuvonen, K.; Kauppinen, T.; Boffetta, P.; Partanen, T. Cancer of the brain and nervous system and occupational exposures in Finnish women. J. Occup. Environ. Med., 2002, 44, 663-668.
28. Hara, T.; Hoshuyama, T.; Takahashi, K.; Delgermaa, V.; Sorahan, T. Cancer risk among Japanese chromium platers, 1976-2003. Scand. J. Work Environ. Health, 2010, 36, 216-221.
29. Bagchi, D.; Vuchetich, P. J.; Bagchi, M.; Hassoun, E. A.; Tran, M. X.; Tang, L.; Stohs, S. J. Induction of oxidative stress by chronic administration of sodium dichromate [chromium VI] and cadmium chloride [cadmium II] to rats. Free Radic. Biol. Med., 1997, 22, 471-478.
30. Travacio, M.; Polo, J. M.; Llesuy, S. Chromium (VI) induces oxidative stress in the mouse brain. Toxicology, 2001, 162, 139-148.
31. Ueno, S.; Kashimoto, T.; Susa, N.; Furukawa, Y.; Ishii, M.; Yokoi, K.; Yasuno, M.; Sasaki, Y. F.; Ueda, J.; Nishimura, Y.; Sugiyama, M. Detection of dichromate (VI)-induced DNA strand breaks and formation of paramagnetic chromium in multiple mouse organs. Toxicol. Appl. Pharmacol., 2001, 170, 56-62.
32. Attenburrow, M. J.; Odontiadis, J.; Murray, B. J.; Cowen, P. J.; Franklin, M. Chromium treatment decreases the sensitivity of 5-HT2A receptors. Psychopharmacology, 2002, 159, 432-436.
33. Alexander, J.; Aaseth, J. Uptake of chromate in human red blood cells and isolated rat liver cells: the role of the anion carrier. Analyst, 1995, 120, 931-933.
34. Wang, Z.; Choudhary, A.; Ledvina, P. S.; Quiocho, F. A. Fine tuning the specificity of the periplasmic phosphate transport receptor: sitedirected mutagenesis, ligand binding, and crystallographic studies. J. Biol. Chem., 1994, 269, 25091-25094.
35. Paxton, H. W.; Austin, J. B. Historical account of the contributions of E. C. Bain. Metall. Mater. Trans. B, 1972, 3, 1035-1042.
36. Gayatri, R.; Rajaram, R.; Ramasami, T. Inhibition of collagenase by Cr (III): its relevance to stabilization of collagen. Biochim. Biophys. Acta, 2000, 1524, 228-237.
37. Schoental, R. Chromium carcinogenesis, formation of epoxyaldehydes and tanning. Br. J. Cancer, 1975, 32, 403-404.
38. Friess, S. L. Carcinogenic risk assessment criteria associated with inhalation of airborne particulates containing chromium (VI/III). Sci. Total Environ., 1989, 86, 109-112.
39. Bartlett, R. J. Chromium cycling in soils and water: links, gaps, and methods. Environ. Health Perspect., 1991, 92, 17-24.
40. De Flora, S.; Petruzzelli, S.; Camoirano, A.; Bennicelli, C.; Romano, M.; Rindi, M.; Ghelarducci, L.; Giuntini, C. Pulmonary metabolism of mutagens and its relationship with lung cancer and smoking habits. Cancer Res., 1987, 47, 4740-4745.
41. Capellmann, M.; Bolt, H. M. Chromium (VI) reducing capacity of ascorbic acid and of human plasma in vitro. Arch. Toxicol., 1992, 66, 45-50.
42. Ishikawa, Y.; Nakagawa, K.; Satoh, Y.; Kitagawa, T.; Sugano, H.; Hirano, T.; Tsuchiya, E. Characteristics of chromate workers' cancers, chromium lung deposition and precancerous bronchial lesions: an autopsy study. Br. J. Cancer, 1994, 70, 160-166.
43. Ishikawa, Y.; Nakagawa, K.; Satoh, Y.; Kitagawa, T.; Sugano, H.; Hirano, T.; Tsuchiya, E. "Hot spots" of chromium accumulation at bifurcations of chromate workers' bronchi. Cancer Res., 1994, 54, 2342-2346.
44. Boffetta, P.; Autier, P.; Boniol, M.; Boyle, P.; Hill, C.; Aurengo, A.; Masse, R.; Thé, G.; Valleron, A. J.; Monier, R.; Tubiana, M. An estimate of cancers attributable to occupational exposures in France. J. Occup. Environ. Med., 2010, 52, 399-406.
45. Kondo, K.; Takahashi, Y.; Ishikawa, S.; Uchihara, H.; Hirose, Y.; Yoshizawa, K.; Tsuyuguchi, M.; Takizawa, H.; Miyoshi, T.; Sakiyama, S.; Monden, Y. Microscopic analysis of chromium accumulation in the bronchi and lung of chromate workers. Cancer, 2003, 98, 2420-2429.
46. Takahashi, Y., Kondo, K., Hirose, T., Nakagawa, H., Tsuyuguchi, M., Hashimoto, M., Sano, T., Ochiai, A., Monden, Y. Microsatellite instability and protein expression of the DNA mismatch repair gene, hMLH1, of lung cancer in chromate-exposed workers. Mol. Carcinog., 2005, 42, 150-158.
47. Ali, A. H.; Kondo, K.; Namura, T.; Senba, Y.; Takizawa, H.; Nakagawa, Y.; Toba, H.; Kenzaki, K.; Sakiyama, S.; Tangoku, A. Aberrant DNA methylation of some tumor suppressor genes in lung cancers from workers with chromate exposure. Mol. Carcinog., 2010, 50, 89-99.
48. Kondo, K.; Hino, N.; Sasa, M.; Kamamura, Y.; Sakiyama, S.; Tsuyuguchi, M.; Hashimoto, M.; Uyama, T.; Monden, Y. Mutations of the p53 gene in human lung cancer from chromate-exposed workers. Biochem. Biophys. Res. Commun., 1997, 239, 95-100.
49. Hainaut, P.; Olivier, M.; Pfeifer, G. P. TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database. Mutagenesis, 2001, 16, 551-553.
50. Coyle, Y. M.; Minahjuddin, A. T.; Hynan, L. S.; Minna, J. D. An ecological study of the association of metal air pollutants with lung cancer incidence in Texas. J. Thorac. Oncol., 2006, 1, 654-661.
51. Bennett, W. P.; Alavanja, M. C.; Blomeke, B.; Vähäkanga, K. H.; Castrén, K.; Welsh, J. A.; Bowman, E. D.; Khan, M. A.; Flieder, D. B.; Harris, C. C. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J. Natl. Cancer Inst., 1999, 91, 2009-2014.
52. Halasova, E.; Matakova, T.; Kavcova, E.; Musak, L.; Letkova, L.; Adamkov, M.; Ondrusova, M.; Bukovska, E.; Singliar, A. Human lung cancer and hexavalent chromium exposure. Neuro Endocrinol. Lett., 2009, 30(Suppl. 1), 182-185.
53. Beveridge R., Pintos J., Parent M. E., Asselin J., Siemiatycki J., 2010. Lung cancer risk associated with occupational exposure to nickel, chromium VI, and cadmium in two population-based casecontrol studies in Montreal. Am. J. Ind. Med., 2010, 53, 476-485.
54. Wyllie, A. H.; Kerr, J. F.; Currie, A. R. Cell death: the significance of apoptosis. Int. Rev. Cytol., 1980, 68, 251-306.
55. Warburg, O. On the origin of cancer cells. Science, 1956, 123, 309-314.
56. Ferreira, L. M. R. Cancer metabolism: the Warburg effect today. Exp. Mol. Pathol., 2010, 89, 372-380.
57. Bianchi, V.; Levis, A. G.; Saggioro, D. Differential cytotoxic activity of potassium dichromate on nucleoside uptake in BHK fibroblasts. Chem. Biol. Interact., 1979, 24, 137-151.
58. Levis, A. G.; Buttignol, M.; Bianchi, V.; Sponza, G. Effects of potassium dichromate on nucleic acid and protein syntheses and on precursor uptake in BHK fibroblasts. Cancer Res., 1978, 38, 110-116.
59. Borthiry, G. R.; Antholine, W. E.; Myers, J. M.; Myers, C. R. Reductive activation of hexavalent chromium by human lung epithelial cells: generation of Cr (V) and Cr (V)-thiol species. J. Inorg. Biochem., 2008, 102, 1449-1462.
60. Sugiyama, M. Effects of vitamin E and vitamin B2 on chromateinduced DNA lesions. Biol. Trace Elem. Res., 1989, 21, 399-404.
61. Sugiyama, M. Effects of vitamins on chromium (VI)-induced damage. Environ. Health Perspect., 1991, 92, 63-70.
62. Sugiyama, M.; Tsuzuki, K.; Lin, X.; Costa, M. Potentiation of sodium chromate (VI)-induced chromosomal aberrations and mutation by vitamin B2 in Chinese hamster V79 cells. Mutat. Res., 1992, 283, 211-214.
63. Shi, X. L.; Dalal, N. S. Chromium (V) and hydroxyl radical formation during the glutathione reductase-catalyzed reduction of chromium (VI). Biochem. Biophys. Res. Commun., 1989, 163, 627-634.
64. Bagchi, D.; Bagchi, M.; Stohs, S. J. Chromium (VI)-induced oxidative stress, apoptotic cell death and modulation of p53 tumor suppressor gene. Mol. Cell. Biochem., 2001, 222, 149-158.
65. Wang, S.; Leonard, S. S.; Ye, J.; Gao, N.; Wang, L.; Shi, X. Role of reactive oxygen species and Cr (VI) in Ras-mediated signal transduction. Mol. Cell. Biochem., 2004, 255, 119-127.
66. Poljśak, B.; Gazdag, Z.; Jenko-Brinovec, Š.; Fujs, Š.; Pesti, M.; Bélagyi, J.; Plesničar, S.; Raspor, P. Pro-oxidative vs antioxidative properties of ascorbic acid in chromium (VI)-induced damage: an in vivo and in vitro approach. J. Appl. Toxicol., 2005, 25, 535-548.
67. Valko, M.; Rhodes, C. J.; Moncol, J.; Izakovic, M.; Mazur, M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact., 2006, 160, 1-40.
68. Azad, N; Rojanasakul, Y.; Vallyathan, V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J. Toxicol. Environ. Health Part B Crit. Rev., 2008, 11, 1-15.
69. Yao, H.; Guo, L.; Jiang, B. H.; Luo, J.; Shi, X. Oxidative stress and chromium (VI) carcinogenesis. J. Environ. Pathol. Toxicol. Oncol., 2008, 27, 77-88.
70. Patlolla, A. K.; Barnes, C.; Hackett, D.; Tchounwou, P. B. Potassium dichromate induced cytotoxicity, genotoxicity and oxidative stress in human liver carcinoma (HepG2) cells. Int. J. Environ. Res. Public Health, 2009, 6, 643-653.
71. Son, Y. O.; Hitron, J. A.; Wang, X.; Chang, Q.; Pan, J.; Zhang, Z.; Liu, J.; Wang.; Lee, J. C.; Shi, X. Cr (VI) induces mitochondrialmediated and caspase-dependent apoptosis through reactive oxygen species-mediated p53 activation in JB6 Cl41 cells. Toxicol. Appl. Pharmacol., 2010, 245, 226-235.
72. Tomaszewski, K. E.; Agarwal, D. K.; Melnick, R. L. In vitro steadystate levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators. Carcinogenesis, 1986, 7, 1871-1876.
73. Martin, B. D.; Schoenhard, J. A.; Sugden, K. D. Hypervalent chromium mimics reactive oxygen species as measured by the oxidantsensitive dyes 2', 7'-dichlorofluorescin and dihydrorhodamine. Chem. Res. Toxicol., 1998, 11, 1402-1410.
74. Asatiani, N.; Sapojnikova, N.; Abuladze, M.; Kartvelishvili, T.; Kulikova, N.; Kiziria, E.; Namchevadze, E.; Holman, H. Y. Effects of Cr (VI) long-term and low dose action on mammalian antioxidant enzymes (an in vitro study). J. Inorg. Biochem., 2004, 98, 490-496.
75. Asatiani, N.; Abuladze, M.; Kartvelishvili, T.; Kulikova, N.; Asanishvili, L.; Holman, H. Y.; Sapojnikova, N. Response of antioxidant defense system to chromium (VI)-induced cytotoxicity defense system to chromium (VI)-induced cytotoxicity in human diploid cells. Biometals, 2010, 23, 161-172.
76. Kim, Y. D.; An, S. C.; Oyama, T.; Kawamoto, T.; Kim, H. Oxidative stress, hogg1 expression and NF-κB activity in cells exposed to low level chromium. J. Occup. Health, 2003, 45, 271-277.
77. Nickens, K. P.; Patierno, S. R.; Ceryak, S. Chromium genotoxicity: a double-edged sword. Chem. Biol. Interact., 2010, 188, 276-288.
78. Snow, E. T.; Shu, L. S. Chromium (III) bound to DNA templates promotes increased polymerase processivity and decreased fidelity during replication in vitro. Biochemistry, 1991, 30, 11238-11245.
79. Patierno, S. R.; Banh, D.; Landolph, J. R. Transformation of C3H/10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead but not soluble calcium chromate: relationship to mutagenesis and internalization of lead chromate particle. Cancer Res., 1988, 48, 5280-5288.
80. Xie, H.; Holmes, A. L.; Wise, S. S.; Huang, S.; Peng, C.; Wise Sr, J. P. Neoplastic transformation of human bronchial cells by lead chromate particles. Am. J. Respir. Cell. Mol. Biol., 2007, 37, 544-552.
81. Xie, H.; Wise, S. S.; Wise Sr, J. P. Deficient repair of particulate hexavalent chromium-induced DNA double strand breaks leads to neoplastic transformation. Mutat. Res. Genet. Toxicol. Environ. Mutagen., 2008, 649, 230-238.
82. Azad, N.; Iyer, A. K. V.; Wang, L.; Lu, Y.; Medan, D.; Castranova, V.; Rojanasakul, Y. Nitric oxide-mediated Bcl-2 stabilization potentiates malignant transformation of human lung epithelial cells. Am. J. Respir. Cell Mol. Biol., 2010, 42, 578-585.
83. Rodrigues, C. F. D.; Urbano, A. M.; Matoso, E.; Carreira, I.; Almeida, A.; Santos, P.; Botelho, F.; Carvalho, L.; Alves, M.; Monteiro, C.; Costa, A. N.; Moreno, V.; Alpoim, M. C. Human bronchial epithelial cells malignantly transformed by hexavalent chromium exhibit an aneuploid phenotype but no microsatellite instability. Mutat. Res. Fundam. Mol. Mech. Mutagen., 2009, 670, 42-52.
84. Urbano, A. M.; Rodrigues, C. F. D., Alpoim, M. C. Hexavalent chromium exposure, genomic instability and lung cancer. Gene Ther. Mol. Biol., 2008, 12, 219-238.
85. Ryberg, D.; Alexander, J. Inhibitory action of hexavalent chromium (Cr (VI)) on the mitochondrial respiration and a possible coupling to the reduction of Cr (VI). Biochem. Pharmacol., 1984, 33, 2461-2466.
86. Ryberg, D.; Alexander, J. Mechanisms of chromium toxicity in mitochondria. Chem. Biol. Interact., 1990, 75, 141-151.
87. Wiegand, H. J.; Ottenwälder, H.; Bolt, H. M. Disposition of a soluble chromate in the isolated perfused rat liver. Xenobiotica, 1986, 16, 839-844.
88. Slade, R.; Stead, A. G.; Graham, J. A.; Hatch, G. E. Comparison of lung antioxidant levels in humans and laboratory animals. Am. Rev. Respir. Dis., 1985, 131, 742-746.
89. Jacob, R. A.; Sotoudeh, G. Vitamin C function and status in chronic disease. Nutr. Clin. Care, 2002, 5, 66-74.
90. Quievryn, G.; Goulart, M.; Messer, J.; Zhitkovich, A. Reduction of Cr (VI) by cysteine: significance in human lymphocytes and formation of DNA damage in reactions with variable reduction rates. Mol. Cell. Biochem., 2001, 222, 107-118
91. Quievryn, G.; Messer, J.; Zhitkovich, A. Carcinogenic chromium (VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells. Biochemistry, 2002, 41, 3156-3167.
92. Karaczyn, A.; Ivanov, S.; Reynolds, M.; Zhitkovich, A.; Kasprzak, K. S.; Salnikow, K. Ascorbate depletion mediates up-regulation of hypoxia-associated proteins by cell density and nickel. J. Cell. Biochem., 2006, 97, 1025-1035.
93. Reynolds, M.; Zhitkovich, A. Cellular vitamin C increases chromate toxicity via a death program requiring mismatch repair but not p53. Carcinogenesis, 2007, 28, 1613-1620.
94. Stearns, D. M.; Wetterhahn, K. E. Reaction of Cr (VI) with ascorbate produces chromium (V), chromium (IV), and carbon-based radicals. Chem. Res. Toxicol., 1994, 7, 219-230.
95. Lay, P. A.; Levina, A. Activation of molecular oxygen during the reactions of chromium (VI/V/IV) with biological reductants: implications for chromium-induced genotoxicities. J. Am. Chem. Soc., 1998, 120, 6704-6714.
96. Standeven, A. M.; Wetterhahn, K. E. Ascorbate is the principal reductant of chromium (VI) in rat liver and kidney ultrafiltrates. Carcinogenesis, 1991, 12, 1733-1737.
97. Standeven, A. M.; Wetterhahn, K. E. Ascorbate is the principal reductant of chromium (VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro. Carcinogenesis, 1992, 13, 1319-1324.
98. Stearns, D. M.; Wetterhahn, K. E. Reaction of Cr (VI) with ascorbate produces chromium (V), chromium (IV), and carbon-based radicals. Chem. Res. Toxicol., 1994, 7, 219-230.
99. Stearns, D. M.; Courtney, K. D.; Giangrande, P. H.; Phieffer, L. S.; Wetterhahn, K. E. Chromium (VI) reduction by ascorbate: role of reactive intermediates in DNA damage in vitro. Environ. Health Perspect., 1994, 102(Suppl. 3), 21-25.
100. Stearns, D. M.; Kennedy, L. J.; Courtney, K. D.; Giangrande, P. H.; Phieffer L. S., Wetterhahn, K. E. Reduction of chromium (VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. Biochemistry, 1995, 34, 910-919.
101. Quievryn, G.; Peterson, E.; Messer, J.; Zhitkovich, A. Genotoxicity and mutagenicity of chromium (VI)/ascorbate-generated DNA adducts in human and bacterial cells. Biochemistry, 2003, 42, 1062-1070.
102. O'Brien, P.; Wang, G.; Wyatt, P. B. Studies on the kinetics of the reduction of chromate by glutathione and related thiols. Polyhedron, 1992, 11, 3211-3216.
103. Borges, K. M.; Boswell, J. S.; Liebross, R. H.; Wetterhahn, K. E. Activation of chromium (VI) by thiols results in chromium (V) formation, chromium binding to DNA and altered DNA conformation. Carcinogenesis, 1991, 12, 551-561
104. Levina, A.; Lay, P. A. Mechanistic studies of relevance to the biological activities of chromium. Coord. Chem. Rev., 2005, 42, 281-298.
105. Zhitkovich, A.; Quievryn, G.; Messer, J.; Motylevich, Z. Reductive activation with cysteine represents a chromium (III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium (VI). Environ. Health Perspect., 2002, 110, 729-731.
106. Shi, X.; Mao, Y.; Knapton, A. D.; Ding, M.; Rojanasakul, Y.; Gannett, P. M.; Dalal, N.; Liu, K. Reaction of Cr (VI) with ascorbate and hydrogen peroxide generates hydroxyl radicals and causes DNA damage: role of a Cr (IV)-mediated Fenton-like reaction. Carcinogenesis, 1994, 15, 2475-2478.
107. Sugden, K. D.; Wetterhahn, K. E. Direct and hydrogen peroxideinduced chromium (V) oxidation of deoxyribose in single-stranded and double-stranded calf thymus DNA. Chem. Res. Toxicol., 1997, 10, 1397-1406.
108. Casadevall, M.; da Cruz Fresco, P.; Kortenkamp, A. Chromium (VI)-mediated DNA damage: oxidative pathways resulting in the formation of DNA breaks and abasic sites. Chem. Biol. Interact., 1999, 123, 117-132.
109. Slade, P. G.; Hailer, M. K.; Martin, B. D.; Sugden, K. D. Guaninespecific oxidation of double-stranded DNA by Cr (VI) and ascorbic acid forms spiroiminodihydantoin and 8-oxo-2'-deoxyguanosine. Chem. Res. Toxicol., 2005, 18, 1140-1149.
110. Shi, X. G.; Dalal, N. S. On the hydroxyl radical formation in the reaction between hydrogen peroxide and biologically generated chromium (V) species. Arch. Biochem. Biophys., 1990, 277, 342-350.
111. Shi, X.; Dalal, N. S. Generation of hydroxyl radical by chromate in biologically relevant systems: role of Cr (V) complexes versus tetraperoxochromate (V). Environ. Health Perspect., 1994, 102, 231-236.
112. Shi, X. L.; Dalal, N. S. ESR spin trapping detection of hydroxyl radicals in the reactions of Cr (V) complexes with hydrogen peroxide. Free Radic. Res. Commun., 1990, 10, 17-26.
113. Shi, X. L; Dalal, N. S. Evidence for a Fenton-type mechanism for the generation of OH radicals in the reduction of Cr (VI) in cellular media. Arch. Biochem. Biophys., 1990, 281, 90-95.
114. Shi, X. L.; Dalal, N. S. One-electron reduction of chromate by NADPH-dependent glutathione reductase. J. Inorg. Biochem., 1990, 40, 1-12.
115. Garcia, J. D.; Jennette, K. W. Electron-transport cytochrome P-450 system is involved in the microsomal metabolism of the carcinogen chromate. J. Inorg. Biochem., 1981, 14, 281-295.
116. Jennette, K. W. Microsomal reduction of the carcinogen chromate produces chromium (V). J. Am. Chem. Soc., 1982, 104, 874-875.
117. Shi, X. L.; Dalal, N. S.; Vallyathan, V. One-electron reduction of carcinogen chromate by microsomes, mitochondria, and Escherichia coli: identification of Cr (V) and OH radical. Arch. Biochem. Biophys., 1991, 290, 381-386.
118. Pratt, P. F.; Myers, C. R. Enzymatic reduction of chromium (VI) by human hepatic microsomes. Carcinogenesis, 1993, 14, 2051-2057.
119. Shi, X.; Dong, Z.; Dalal, N. S.; Gannett, P. M. Chromate-mediated free radical generation from cysteine, penicillamine, hydrogen peroxide, and lipid hydroperoxides. Biochim. Biophys. Acta, 1994, 1226, 65-72.
120. Kawanishi, S.; Inoue, S.; Sano, S. Mechanism of DNA cleavage induced by sodium chromate (VI) in the presence of hydrogen peroxide. J. Biol. Chem., 1986, 261, 5952-5958.
121. Beaver, L. M.; Stemmy, E. J.; Constant, S. L.; Schwartz, A.; Little, L. G.; Gigley, J. P.; Chun, G.; Sugden, K. D.; Ceryak, S. M.; Patierno, S. R. Lung injury, inflammation and Akt signaling following inhalation of particulate hexavalent chromium. Toxicol. Appl. Pharmacol., 2009, 235, 47-56.
122. Kim, E. Y.; Seo, J. M.; Cho, K. J.; Kim, J. H. Ras-induced invasion and metastasis are regulated by a leukotriene B4 receptor BLT2-linked pathway. Oncogene, 2010, 29, 1167-1178.
123. Voitkun, V.; Zhitkovich, A.; Costa, M. Cr (III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells. Nucleic Acids Res., 1998, 26, 2024-2030.
124. Salnikow, K.; Zhitkovich, A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem. Res. Toxicol., 2008, 21, 28-44.
125. Ahmad, I. M.; Aykin-Burnsm N.; Sim, J. E.; Walsh, S. A.; Higashikubo, R.; Buettner, G. R.; Venkataraman, S.; Mackey, M. A.; Flanagan, S. W.; Oberley, L. W.; Spitz, D. R. Mitochondrial O2*-and H2O2 mediate glucose deprivation-induced stress in human cancer cells. J. Biol. Chem., 2005, 280, 4254-4263.
126. Kregel, K. C.; Zhang, H. J. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2007, 292, R18-R36.
127. Villalba, J. M.; Navas, P. Plasma membrane redox system in the control of stress-induced apoptosis. Antioxid. Redox Signal., 2000, 2, 213-230.
128. Ahn, S. G.; Thiele, D. J. Redox regulation of mammalian heat shock factor 1 is essential for Hsp gene activation and protection from stress. Genes Dev., 2003, 17, 516-528.
129. Schulz, G. E.; Schirmer, R. H.; Sachsenheimer, W.; Pai, E. F. The structure of the flavoenzyme glutathione reductase. Nature, 1978, 273, 120-124.
130. Powis, G.; Montfort, W. R. Properties and biological activities of thioredoxins. Ann. Rev. Biophys. Biomol. Struct., 2001, 30, 421-455.
131. Myers, J. M.; Antholine, W. E.; Myers, C. R. Hexavalent chromium causes the oxidation of thioredoxin in human bronchial epithelial cells. Toxicol., 2008, 246, 222-233.
132. Koutras, G. A.; Hattori, M.; Schneider, A. S.; Ebaugh Jr, F. G.; Valentine, W. N. Studies on chromated erythrocytes. Effect of sodium chromate on erythrocyte glutathione reductase. J. Clin. Invest., 1964, 43, 323-331.
133. Tsapakos, M. J.; Hampton, T. H.; Wetterhahn, K. E. Chromium (VI) - induced DNA lesions and chromium distribution in rat kidney, liver, and lung. Cancer Res., 1983, 43, 5662-5667.
134. Arakawa, H.; Ahmad, R.; Naoui, M.; Tajmir-Riahi, H. A. A comparative study of calf thymus DNA binding to Cr (III) and Cr (VI) ions - Evidence for the guanine N-7-chromium-phosphate chelate formation. J. Biol. Chem., 2000, 275, 10150-10153.
135. Zhitkovich, A. Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium (VI). Chem. Res. Toxicol., 2005, 18, 3-11.
136. Zhitkovich, A.; Voitkun, V.; Costa, M. Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate. Carcinogenesis, 1995, 16, 907-913.
137. O'Brien, T. J.; Ceryak, S.; Patierno, S. R. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat. Res. Fundam. Mol. Mech. Mutagen., 2003, 533, 3-36.
138. Sugden, K. D.; Stearns, D. M. The role of chromium (V) in the mechanism of chromate-induced oxidative DNA damage and cancer. J. Environ. Pathol. Toxicol. Oncol., 2000, 19, 215-230.
139. Macfie, A.; Hagan, E.; Zhitkovich, A. Mechanism of DNA-protein cross-linking by chromium. Chem. Res. Toxicol., 2010, 23, 341-347.
140. Bridgewater, L. C.; Manning, F. C.; Patierno, S. R. Arrest of replication by mammalian DNA polymerases alpha and beta caused by chromium-DNA lesions. Mol. Carcinog., 1998, 23, 201-206.
141. O'Brien, T.; Xu, J.; Patierno, S. R. Effects of glutathione on chromiuminduced DNA cross-linking and DNA polymerase arrest. Mol. Cell. Biochem., 2001, 222, 173-182.
142. O'Brien, T. J.; Mandel, H. G.; Pritchard, D. E.; Patierno, S. R. Critical role of chromium (Cr)-DNA interactions in the formation of Crinduced polymerase arresting lesions. Biochemistry, 2002, 41, 12529-12537.
143. Zhitkovich, A.; Messer, J.; Shrager, S. Reductive metabolism of Cr (VI) by cysteine leads to the formation of binary and ternary Cr-DNA adducts in the absence of oxidative DNA damage. Chem. Res. Toxicol., 2000, 13, 1114-1124.
144. Hodges, N. J.; Chipman, J. K. Down-regulation of the DNA-repair endonuclease 8-oxo-guanine DNA glycosylase 1 (hOGG1) by sodium dichromate in cultured human A549 lung carcinoma cells. Carcinogenesis, 2002, 23, 55-60.
145. Carson, B. L.; Ellis, H. V.; McCann, J. L. Toxicology and Biological Monitoring of Metals in Humans; Lewis Publishers: Chelsea, 1986.
146. Monographs on the Evaluation of Carcinogenic Risks to Humans. 1990, 49, 49-256, World Health Organization, Lyon, France.
147. Saleh-Gohari, N.; Bryant, H. E.; Schultz, N.; Parker, K. M.; Cassel, T. N.; Helleday, T. Spontaneous homologous recombination is induced by collapsed replication forks that are caused by endogenous DNA single-strand breaks. Mol. Cell Biol., 2005, 25, 7158-7169.
148. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 1997, 88, 323-331.
149. Hahn, W. C.; Weinberg, R. A. Rules for making human tumor cells. N. Engl. J. Med., 2002, 347, 1593-1603.
150. Courcelle, J.; Donaldson, J. R.; Chow, K. H.; Courcelle, C. T. DNA damage-induced replication fork regression and processing in Escherichia coli. Science, 2003, 299, 1064-1067.
151. Messer, J.; Reynolds, M.; Stoddard, L.; Zhitkovich, A. Causes of DNA single-strand breaks during reduction of chromate by glutathione in vitro and in cells. Free Radic. Biol. Med., 2006, 40, 1981-1992.
152. Casadevall, M.; Kortenkamp, A. The generation of apurinic/apyrimidinic sites in isolated DNA during the reduction of chromate and glutathione. Carcinogenesis, 1994, 15, 407-409.
153. Casadevall, M.; Kortenkamp, A. The formation of both apurinic/ apyrimidinic sites and single strand breaks by chromate and glutathione arises from attack by the same reactive species and is dependent on molecular oxygen. Carcinogenesis, 1995, 16, 805-809.
154. Molyneux, M. J.; Davies, M. J. Direct evidence for hydroxyl radicalinduced damage to nucleic acids by chromium (VI)-derived species: implications for chromium carcinogenesis. Carcinogenesis, 1995, 16, 875-882.
155. Bose, R. N.; Fonkeng, B. S.; Moghaddas, S.; Stroup, D. Mechanisms of DNA damage by chromium (V) carcinogens. Nucleic Acids Res., 1998, 26, 1588-1596.
156. Bose, R. N.; Moghaddas, S.; Mazzer, P. A.; Dudones, L. P.; Joudah, L.; Stroup, D. Oxidative damage of DNA by chromium (V) complexes: relative importance of base versus sugar oxidation. Nucleic Acids Res., 1999, 27, 2219-2226.
157. Janson, C. A., Cleland, W. W. The inhibition of acetate, pyruvate and 3-phosphoglycerate kinases by chromium adenosine triphosphate. J. Biol. Chem., 1974, 249, 2567-2571.
158. Bianchi, V.; Debetto, P.; Zantedeschi, A.; Levis, A. G. Effects of hexavalent chromium on the adenylate pool of hamster fibroblasts. Toxicology, 1982, 25, 19-30.
159. Bridgewater, L. C.; Manning, F. C.; Patierno, S. R. Base-specific arrest of in vitro DNA replication by carcinogenic chromium: relationship to DNA interstrand crosslinking. Carcinogenesis, 1994, 15, 2421-2427.
160. Fornace Jr, A. J.; Seres, D. S.; Lechner, J. F.; Harris, C. C. DNAprotein cross-linking by chromium salts. Chem. Biol. Interact., 1981, 36, 345-354.
161. Sugden, K. D.; Martin, B. D. Guanine and 7, 8-dihydro-8- oxoguaninespecific oxidation in DNA by chromium (V). Environ. Health Perspect., 2002, 110(Suppl. 5), 725-728.
162. Xu, J.; Manning, F. C.; O'Brien, T. J.; Ceryak, S.; Patierno, S. R. Mechanisms of chromium-induced suppression of RNA synthesis in cellular and cell-free systems: relationship to RNA polymerase arrest. Mol. Cell. Biochem., 2004, 255, 151-160.
163. Wang, J. F.; Bashir, M.; Engelsberg, B. N.; Witmer, C.; Rozmiarek, H.; Billings, P. C. High mobility group proteins 1 and 2 recognize chromium-damaged DNA. Carcinogenesis, 1997, 18, 371-375.
164. Zakour, R. A.; Kunkel, T. A.; Loeb, L. A. Metal-induced infidelity of DNA synthesis. Environ. Health Perspect., 1981, 40, 197-205.
165. Sirover, M. A. Effects of metals in in vitro bioassays. Environ. Health Perspect., 1981, 40, 163-172.
166. Reynolds, M.; Stoddard, L.; Bespalov, I.; Zhitkovich, A. Ascorbate acts as a highly potent inducer of chromate mutagenesis and clastogenesis: linkage to DNA breaks in G2 phase by mismatch repair. Nucleic Acids Res., 2007, 35, 465-476.
167. Guttmann, D.; Poage, G.; Johnston, T.; Zhitkovich, A. Reduction with glutathione is a weakly mutagenic pathway in chromium (VI) metabolism. Chem. Res. Toxicol., 2008, 21, 2188-2194.
168. Cheng, L.; Sonntag, D. M; de Boer, J.; Dixon, K. Chromium (VI) - induced mutagenesis in the lungs of big blue transgenic mice. J. Environ. Pathol. Toxicol. Oncol., 2000, 19, 239-249.
169. Hanahan, D.; Weinberg, R. A. Halmarks of cancer: the next generation. Cell, 2011, 144, 646-674.
170. Medeiros, M. G.; Rodrigues, A. S.; Batoréu, M. C.; Laires, A.; Rueff, J.; Zhitkovich, A. Elevated levels of DNA-protein crosslinks and micronuclei in peripheral lymphocytes of tannery workers exposed to trivalent chromium. Mutagenesis, 2002, 18, 19-24.
171. Howard, W. R.; Hoffman, S. A.; Kochhar, T. S., Enhanced production of
172. Gisselsson, D.; Jonson, T.; Petersén, A.; Strömbeck, B.; Dal Cin, P.; Höglund, M.; Mitelman, F.; Mertens, F.; Mandahl, N. Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc. Natl. Acad. Sci. USA., 2001, 98, 2683-2688.
173. Glaser, U.; Hochrainer, D.; Kloppel, H.; Oldiges, H. Carcinogenicity of sodium dichromate and chromium (VI/III) oxide aerosols inhaled by male Wistar rats. Toxicology, 1986, 42, 219-232.
174. Levy, L. S.; Martin, P. A.; Bidstrup, P. L. Investigation of the potential carcinogenicity of a range of chromium containing materials on rat lung. Br. J. Ind. Med., 1986, 43, 243-256.
175. Steinhoff D, Gad S. C., Hatfield G. K., Mohr U. Carcinogenicity study with sodium dichromate in rats. Exp. Pathol., 1986, 30, 129-141.
176. Balansky, R. M; D'Agostini, F.; Izzotti, A.; De Flora, S. Less than additive interaction between cigarette smoke and chromium (VI) in inducing clastogenic damage in rodents. Carcinogenesis, 2000, 21, 1677-1682.
177. D'Agostini, F.; Izzotti, A.; Bennicelli, C.; Camoirano, A.; Tampa, E.; De Flora, S. Induction of apoptosis in the lung but not in the liver of rats receiving intra-tracheal instillations of chromium (VI). Carcinogenesis, 2002, 23, 587-593.
178. Wise, S. S.; Holmes, A. L.; Wise Sr, J. P. Hexavalent chromiuminduced DNA damage and repair mechanisms. Rev. Environ. Health, 2008, 23, 39-57.
179. Hueper, W. C. Experimental studies in metal cancerigenesis. X. Cancerigenic effects of chromite ore roast deposited in muscle tissue and pleural cavity of rats. AMA Arch. Ind. Health, 1958, 18, 284-291.
180. Baetjer, A. M.; Lowney, J. F.; Steffee, H.; Budacz, V. Effect of chromium on incidence of lung tumors in mice and rats. AMA Arch. Ind. Health, 1959, 20, 124-135.
181. Hueper, W. C.; Payne W. W. Experimental cancers in rats produced by chromium compounds and their significance to industry and public health. Amer. Industr. Hyg. Assoc. J., 1959, 20, 274-280.
182. Hueper, W. C.; Payne, W. W. Experimental studies in metal carcinogenesis. Chromium, nickel, iron, arsenic. Arch. Environ. Health, 1962, 5, 445-462.
183. Roe, F. J.; Carter, R. L. Chromium carcinogenesis: calcium chromate as a potent carcinogen for the subcutaneous tissues of the rat. Br. J. Cancer, 1969, 23, 172-176.
184. Nettesheim, P.; Hanna Jr, M. G; Doherty, D. G.; Newell, R. F.; Hellman, A. Effect of calcium chromate dust, influenza virus, and 100 R whole-body x radiation on lung tumor incidence in mice. J. Natl. Cancer Inst., 1971, 47, 1129-1144.
185. Furst, A.; Schlauder, M.; Sasmore, D. P. Tumorigenic activity of lead chromate. Cancer Res., 1976, 36, 1779-1783.
186. Levy, L. S.; Venitt, S. Carcinogenicity and mutagenicity of chromium compounds: the association between bronchial metaplasia and neoplasia. Carcinogenesis, 1986, 7, 831-835.
187. Wise, J. P.; Orenstein, J. M.; Patierno, S. R. Inhibition of lead chromate clastogenesis by ascorbate: relationship to particle dissolution and uptake. Carcinogenesis, 1993, 14, 429-434.
188. Wise Sr, J. P.; Stearns, D. M.; Wetterhahn, K. E.; Patierno, S. R. Cellenhanced dissolution of carcinogenic lead chromate particles: the role of individual dissolution products in clastogenesis. Carcinogenesis, 1994, 15, 2249-2254.
189. Xie, H.; Holmes, A. L.; Wise, S. S.; Gordon, N.; Wise Sr, J. P. Lead chromate-induced chromosome damage requires extracellular dissolution to liberate chromium ions but does not require particle internalization or intracellular dissolution. Chem. Res. Toxicol., 2004, 17, 1362-1367
190. Holmes, A. L.; Wise, S. S.; Xie, H.; Gordon, N.; Thompson, W. D.; Wise Sr, J. P. Lead ions do not cause human lung cells to escape chromate-induced cytotoxicity. Toxicol. Appl. Pharmacol., 2005, 203, 167-176.
191. Wise Sr, J. P.; Wise, S. S.; Little, J. E. The cytotoxicity and genotoxicity of particulate and soluble hexavalent chromium in human lung cells. Mutat. Res. Genet. Toxicol. Environ. Mutagen., 2002, 517, 221-229.
192. Wise, S. S.; Holmes, A. L.; Qin, Q.; Xie, H.; Katsifis, S. P.; Thompson, W. D.; Wise, J. P. Comparative genotoxicity and cytotoxicity of four hexavalent chromium compounds in human bronchial cells. Chem. Res. Toxicol., 2010, 23, 365-372.
193. Liang, Y. J.; Zhou, P.; Wongba, W.; Guardiola, J.; Walker, J.; Yu, J. Pulmonary innervation, inflammation and carcinogenesis. Acta Physiol. Sin., 2010, 62, 191-195.
194. Glaser, U.; Hochrainer, D.; Kloppel, H.; Kuhnen, H. Low level chromium (VI) inhalation effects on alveolar macrophages and immune functions in Wistar rats. Arch. Toxicol., 1985, 57, 250-256.
195. Johansson, A.; Wiernik, A.; Jarstrand, C.; Camner, P. Rabbit alveolar macrophages after inhalation of hexa-and trivalent chromium. Environ. Res., 1986, 39, 372-385.
196. Johansson, A.; Robertson, B.; Curstedt, T.; Camner, P. Rabbit lung after inhalation of hexa-and trivalent chromium. Environ. Res., 1986, 41, 110-119.
197. Beaver, L. M.; Stemmy, E. J.; Schwartz, A. M.; Damsker, J. M.; Constant, S. L.; Ceryak, S. M.; Patierno, S. R. Lung inflammation, injury, and proliferative response after repetitive particulate hexavalent chromium exposure. Environ. Health Perspect., 2009, 117, 1896-1902.
198. Heidemann, E. Fundamentals of Leather Manufacturing; Druckerei und Verlag: Darmstad, 1993.
199. Stickland, L. H. The activation of phosphoglucomutase by metal ions. Biochem. J., 1949, 44, 190-197.
200. Evans, M. J.; Saghatelian, A.; Sorensen, E. J.; Cravatt, B. F. Target discovery in small-molecule cell-based screens by in situ proteome reactivity profiling. Nat. Biotechnol., 2005, 23, 1303-1307.
201. Lippard, S. J.; Berg, J. M. Principles of Bioinorganic Chemistry; University Science Books: New York, 1997.
202. Janson, C. A.; Cleland, W. W. The specificity of chromium nucleotides as inhibitors of selected kinases. J. Biol. Chem., 1974, 249, 2572-2574.
203. Bossard, M. J.; Schuster, S. M. Structural preferences for the binding of chromium nucleotides by beef heart mitochondrial ATPase. J. Biol. Chem., 1981, 256, 6617-6622.
204. Sanadi, D. R.; Langley, M.; White, F. Alpha-ketoglutaric dehydrogenase. 7. The role of thioctic acid. J. Biol. Chem., 1959, 234, 183-187.
205. Wieland, O. The mammalian pyruvate dehydrogenase complex: structure and regulation. Rev. Physiol. Biochem. Pharmacol., 1983, 96, 123-170.
206. Altenberg, B.; Greulich, K. O. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics, 2004, 84, 1014-1020.
207. Sumner, E. R.; Shanmuganathan, A.; Sideri, T. C.; Willetts, S. A.; Houghton, J. E.; Avery, S. V. Oxidative protein damage causes chromium toxicity in yeast. Microbiol., 2005, 151, 1939-1948.
208. Hartwell, L. H.; Weinert, T. A. Checkpoints: controls that ensure the order of cell cycle events. Science, 1989, 246, 629-634.
209. Blankenship, L. J.; Manning, F. C.; Orenstein, J. M.; Patierno, S. R. Apoptosis is the mode of cell death caused by carcinogenic chromium. Toxicol. Appl. Pharmacol., 1994, 126, 75-83.
210. Xu, J.; Bubley, G. J.; Detrick, B.; Blankenship, L. J.; Patierno, S. R. Chromium (VI) treatment of normal human lung cells results in guaninespecific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle. Carcinogenesis, 1996, 17, 1511-1517.
211. Singh, J.; Carlisle, D. L.; Pritchard, D. E.; Patierno, S. R. Chromiuminduced genotoxicity and apoptosis: relationship to chromium carcinogenesis (review). Oncol. Rep., 1998, 5, 1307-1318.
212. Singh, J.; Pritchard, D. E.; Carlisle, D. L.; Mclean, J. A.; Montaser, A.; Orenstein, J. M.; Patierno, S. R. Internalization of carcinogenic lead chromate particles by cultured normal human lung epithelial cells: formation of intracellular lead-inclusion bodies and induction of apoptosis. Toxicol. Appl. Pharmacol., 1999, 161, 240-248.
213. Carlisle, D. L; Pritchard, D. E; Singh, J.; Owens, B. M.; Blankenship, L. J.; Orenstein, J. M.; Patierno, S. R. Apoptosis and p53 induction in human lung fibroblasts exposed to chromium (VI): effect of ascorbate and tocopherol. Toxicol. Sci., 2000, 55, 60-68.
214. Carlisle, D. L.; Pritchard, D. E.; Singh, J.; Patierno, S. R. Chromium (VI) induces p53-dependent apoptosis in diploid human lung and mouse dermal fibroblasts. Mol. Carcinog., 2000, 28, 111-118.
215. Ha, L.; Ceryak, S.; Patierno, S. R. Chromium (VI) activates ataxia telangiectasia mutated (ATM) protein. Requirement of ATM for both apoptosis and recovery from terminal growth arrest. J. Biol. Chem., 2003, 278, 17885-17894.
216. Wakeman, T. P.; Kim, W. J.; Callens, S.; Chiu, A.; Brown, K. D.; Xu, B. The ATM-SMC1 pathway is essential for activation of the chromium[VI]-induced S-phase checkpoint. Mutat. Res. Fundam. Mol. Mech. Mutagen., 2004, 554, 241-251.
217. Pritchard, D. E.; Ceryak, S.; Ramsey, K. E.; O'Brien, T. J.; Ha, L.; Fornsaglio, J. L.; Stephan, D. A.; Patierno, S. R. Resistance to apoptosis, increased growth potential, and altered gene expression in cells that survived genotoxic hexavalent chromium [Cr (VI)] exposure. Mol. Cell. Biochem., 2005, 279, 169-181.
218. Russo, P.; Catassi, A.; Cesario, A.; Imperatori, A.; Rotolo, N.; Fini, M.; Granone, P.; Dominioni, L. Molecular mechanisms of hexavalent chromium-induced apoptosis in human bronchoalveolar cells. Am. J. Respir. Cell. Mol. Biol., 2005, 33, 589-600.
219. Quinteros, F. A.; Machiavelli, L. I.; Miler, E. A.; Cabilla, J. P.; Duvilanski, B. H. Mechanisms of chromium (VI)-induced apoptosis in anterior pituitary cells. Toxicology, 2008, 249, 109-115.
220. Costa, A. N.; Moreno, V.; Prieto, M. J.; Urbano, A. M.; Alpoim, M. C. Induction of morphological changes in BEAS-2B human bronchial epithelial cells following chronic sub-cytotoxic and mildly cytotoxic hexavalent chromium exposures. Mol. Carcinog., 2010, 49, 582-591.
221. Azad, N.; Iyer, A. K.; Manosroi, A.; Wang, L.; Rojanasakul, Y. Superoxide mediated proteasomal degradation of Bcl-2 determines cell susceptibility to Cr (VI)-induced apoptosis. Carcinogenesis, 2008, 29, 1538-1545.
222. Almeida, K. H.; Sobol, R. W. A unified view of base excision repair: lesion-dependent protein complexes regulated by post-translational modification. DNA Repair, 2007, 6, 695-711.
223. Wikman, H.; Risch, A.; Klimek, F.; Schmezer, P.; Spiegelhalder, B.; Dienemann, H.; Kayser, K.; Schulz, V.; Drings, P.; Bartsch, H. hOGG1 polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a caucasian population. Int. J. Cancer, 2000, 88, 932-937.
224. Audebert, M.; Chevillard, S.; Levalois, C.; Gyapay, G.; Vieillefond, A.; Klijanienko, J.; Vielh, P.; El Naggar, A. K.; Oudard, S.; Boiteux, S.; Radicella, J. P. Alterations of the DNA repair gene OGG1 in human clear cell carcinomas of the kidney. Cancer Res., 2000, 60, 4740-4744.
225. Audebert, M.; Radicella, J. P.; Dizdaroglu, M. Effect of single mutations in the OGG1 gene found in human tumors on the substrate specificity of the OGG1 protein. Nucleic Acids Res., 2000, 28, 2672-2678.
226. Hodges, N. J.; Adám, B.; Lee, A. J.; Cross, H. J.; Chipman, J. K. Induction of DNA-strand breaks in human peripheral blood lymphocytes and A549 lung cells by sodium dichromate: association with 8-oxo-2-deoxyguanosine formation and inter-individual variability. Mutagenesis, 2001, 16, 467-474.
227. Cheng, L.; Liu, S.; Dixon, K. Analysis of repair and mutagenesis of chromium-induced DNA damage in yeast, mammalian cells, and transgenic mice. Environ. Health Perspect., 1998, 106, 1027-1032.
228. Brooks, B.; O'Brien, T. J.; Ceryak, S.; Sr Wise, J. P.; Wise, S. S.; Jr Wise, J. P.; De Fabo, E.; Patierno, S. R. Excision repair is required for genotoxin-induced mutagenesis in mammalian cells. Carcinogenesis, 2008, 29, 1064-1069.
229. Grlickova-Duzevik, E.; Wise, S. S.; Munroe, R. C.; Thompson, W. D.; Wise Sr, J. P. XRCC1 protects against particulate chromateinduced chromosome damage and cytotoxicity in Chinese hamster ovary cells. Toxicol. Sci., 2006, 92, 409-415.
230. Grlickova-Duzevika, E.; Wise, S. S.; Munroe, R. C.; Douglas W.; Thompson, W. D.; Wise Sr, J. P. XRCC1 protects cells from chromateinduced chromosome damage, but does not affect cytotoxicity. Mutat. Res. Genet. Toxicol. Environ. Mutagen., 2006, 610, 31-37.
231. Masuda, A.; Takahashi, T. Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis. Oncogene, 2002, 21, 6884-6897.
232. Nakamura, H.; Saji, H.; Idiris, A.; Kawasaki, N.; Hosaka, M.; Ogata, A.; Saijo, T.; Kato, H. Chromosomal instability detected by fluorescence in situ hybridization in surgical specimens in nonsmall cell lung cancer is associated with poor survival. Clin. Cancer Res., 2003, 9, 2294-2299.
233. Hirose, T.; Kondo, K.; Takahashi, Y.; Ishikura, H.; Fujino, H.; Tsuyuguchi, M.; Hashimoto, M.; Yokose, T.; Mukai, K.; Kodama, T.; Monden Y. Frequent microsatellite instability in lung cancer from chromate-exposed workers. Mol. Carcinog., 33, 2002, 172-180.
234. Blankert, S. A.; Coryell, V. H.; Picard, B. T.; Wolf, K. K.; Lomas, R. E.; Stearns, D. M. Characterization of nonmutagenic Cr (III)-DNA interactions. Chem. Res. Toxicol., 2003, 16, 847-854.
235. Reynolds, M.; Peterson, E.; Quievryn, G.; Zhitkovich, A. Human nucleotide excision repair efficiently removes chromium-DNA phosphate adducts and protects cells against chromate toxicity. J. Biol. Chem., 2004, 279, 30419-30424
236. O'Brien, T. J.; Brooks, B. R.; Patierno, S. R. Nucleotide excision repair functions in the removal of chromium-induced DNA damage in mammalian cells. Mol. Cell. Biochem., 2005, 279, 85-95.
237. Sancar, A. DNA excision repair. Annu. Rev. Biochem., 1996, 65, 43-81.
238. Wood, R. D. DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie, 1999, 81, 39-44;
239. de Boer, J.; Hoeijmakers, J. H. Nucleotide excision repair and human syndromes. Carcinogenesis, 2000, 21, 453-460
240. Tark, M.; Tover, A.; Koorits, L.; Tegova, R.; Kivisaar, M. Dual role of NER in mutagenesis in Pseudomonas putida. DNA Repair, 2008, 7, 20-30.
241. O'Brien, T. J.; Witcher, P.; Brooks, B.; Patierno, S. R. DNA polymerase zeta is essential for hexavalent chromium-induced mutagenesis. Mutat. Res. Fundam. Mol. Mech. Mutagen., 663, 77-83.
242. Li, G. M. Mechanisms and functions of DNA mismatch repair. Cell Res., 2008, 18, 85-98.
243. Genschel, J.; Modrich, P. Mechanism of 5'-directed excision in human mismatch repair. Mol. Cell, 2003, 12, 1077-1086.
244. Zhang, Y.; Yuan, F.; Presnell, S. R.; Tian, K.; Gao, Y.; Tomkinson, A. E.; Gu, L.; Li, G. M. Reconstitution of 5-directed human mismatch repair in a purified system. Cell, 2005, 122, 693-705.
245. Hickman, M. J.; Samson, L. D. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc. Natl. Acad. Sci. U. S. A., 1999, 96, 10764-10769.
246. Cejka, P.; Stojic, L.; Mojas, N.; Russell, A. M.; Heinimann, K.; Cannavó, E.; di Pietro, M.; Marra, G.; Jiricny, J. Methylationinduced G (2)/M arrest requires a full complement of the mismatch repair protein hMLH1. EMBO J., 2003, 22, 2245-2254.
247. Aebi, S.; Kurdi-Haidar, B.; Gordon, R.; Cenni, B.; Zheng, H.; Fink, D.; Christen, R. D.; Boland, C. R.; Koi, M.; Fishel, R.; Howell, S. B. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res., 1996, 56, 3087-3090.
248. Fink, D.; Zheng, H.; Nebel, S.; Norris, P. S.; Aebi, S.; Lin, T. P.; Nehmé, A.; Christen, R. D.; Haas, M.; MacLeod, C. L.; Howell, S. B. In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res., 1997, 57, 1841-1845.
249. Swann, P. F.; Waters, T. R.; Moulton, D. C; Xu, Y. Z.; Zheng, Q.; Edwards, M.; Mace, R. Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science, 1996, 273, 1109-1111.
250. Yan, T.; Berry, S. E.; Desai, A. B.; Kinsella, T. J. DNA mismatch repair (MMR) mediates 6-thioguanine genotoxicity by introducing single-strand breaks to signal a G2-M arrest in MMR-proficient RKO cells. Clin. Cancer Res., 2003, 9, 2327-2334;
251. Meyers, M.; Wagner, M. W.; Mazurek, A.; Mazurek, A.; Schmutte, C.; Fishel, R.; Boothman, D. A. DNA mismatch repair-dependent response to fluoropyrimidine-generated damage. J. Biol. Chem., 2005, 280, 5516-5526.
252. Peterson-Roth, E.; Reynolds, M.; Quievryn, G.; Zhitkovich, A. Mismatch repair proteins are activators of toxic responses to chromium-DNA damage. Mol. Cell. Biol., 2005, 25, 3596-3607.
253. Fishel, R. Signaling mismatch repair in cancer. Nat. Med., 1999, 5, 1239-1241
254. Boyer, J. C.; Umar, A.; Risinger, J. I.; Lipford, J. R.; Kane, M.; Yin, S.; Barrett, J. C.; Kolodner, R. D.; Kunkel, T. A. Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res., 1995, 55, 6063-6070.
255. Li, G. M.; Modrich, P. Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. Proc. Natl. Acad. Sci. USA., 1995, 92, 1950-1954.
256. Acharya, S.; Wilson, T.; Gradia, S.; Kane, M. F.; Guerrette, S.; Marsischky, G. T.; Kolodner, R.; Fishel, R. hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. Proc. Natl. Acad. Sci. USA., 1996, 93, 13629-13634.
257. Genschel, J.; Littman, S. J.; Drummond, J. T.; Modrich, P. Isolation of MutSb from human cells and comparison of the mismatch repair specificities of MutSb and MutSa. J. Biol. Chem., 1998, 273, 19895-198901.
258. Genschel, J.; Modrich, P. Functions of MutLα, Replication Protein A (RPA), and HMGB1 in 5'-directed mismatch repair. J. Biol. Chem., 2009, 284, 21536-21544.
259. Shimada, K.; Pasero, P.; Gasser, S. M. ORC and the intra-S-phase checkpoint: a threshold regulates Rad53p activation in S phase. Genes Dev., 2002, 16, 3236-3252.
260. Iyer, R. R.; Pluciennik, A.; Burdett, V.; Modrich, P. L. DNA mismatch repair: functions and mechanisms. Chem. Rev., 2006, 106, 302-323.
261. Fukui K. DNA mismatch repair in eukaryotes and bacteria. J. Nucleic Acids, 2010, Article ID 260512.
262. Stojic, L.; Mojas, N.; Cejka, P.; Di Pietro, M.; Ferrari, S.; Marra, G.; Jiricny, J. Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase. Genes Dev., 2004, 18, 1331-1344.
263. Mojas, N.; Lopes, M.; Jiricny, J. Mismatch repair-dependent processing of methylation damage gives rise to persistent singlestranded gaps in newly replicated DNA. Genes Dev., 2007, 21, 3342-3355.
264. Ha, L.; Ceryak, S.; Patierno, S. R. Generation of S phase-dependent DNA double-strand breaks by Cr (VI) exposure: involvement of ATM in Cr (VI) induction of γ-H2AX. Carcinogenesis, 2004, 25, 2265-2274.
265. Reynolds, M. F.; Peterson-Roth, E. C.; Bespalov, I. A.; Johnston, T.; Gurel V. M.; Menard, H. L.; Zhitkovich, A. Rapid DNA doublestrand breaks resulting from processing of Cr-DNA cross-links by both MutS dimers. Cancer Res., 2009, 69, 1071-1079
266. Zecevic, A.; Menard, H.; Gurel, V.; Hagan, E.; De Caro, R.; Zhitkovich, A. WRN helicase promotes repair of DNA doublestrand breaks caused by aberrant mismatch repair of chromium-DNA adducts. Cell Cycle, 2009, 8, 2769-2778.
267. Rogakou, E. P.; Pilch, D. R.; Orr, A. H.; Ivanova, V. S.; Bonner, W. M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem., 1998, 273, 5858-5868.
268. Schultz, L. B.; Chehab, N. H.; Malikzay, A.; Halazonetis, T. D. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J. Cell Biol., 2000, 151, 1381-1390.
269. Wakeman, T. P.; Xu, B. ATR regulates hexavalent chromiuminduced S-phase checkpoint through phosphorylation of SMC1. Mutat. Res. Genet. Toxicol. Environ. Mutagen., 2006, 610, 14-20.
270. Xie, H.; Holmes, A. L.; Young, J. L.; Qin, Q.; Joyce, K.; Pelsue, S. C.; Peng, C.; Wise, S. S.; Jeevarajan, A. S.; Wallace, W. T.; Hammond, D.; Wise Sr, J. P. Zinc chromate induces chromosome instability and DNA double strand breaks in human lung cells. Toxicol. Appl. Pharmacol., 2009, 234, 293-299.
271. Whitfield, M. L.; Sherlock, G.; Saldanha, A. J.; Murray, J. I.; Ball, C. A.; Alexander, K. E.; Matese, J. C.; Perou, C. M.; Hurt, M. M.; Brown, P. O.; Botstein, D. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell, 2002, 13, 1977-2000.
272. Rich, T.; Allen, R. L.; Wyllie, A. H. Defying death after DNA damage. Nature, 2000, 407, 777-783.
273. Zhitkovich, A.; Peterson-Roth, E.; Reynolds, M. Killing of chromiumdamaged cells by mismatch repair and its relevance to carcinogenesis. Cell Cycle, 2005, 4, 1050-1052.
274. Ohnuki, Y.; Reddel, R. R.; Bates, S. E.; Lehman, T. A.; Lechner, J. F.; Harris, C. C. Chromosomal changes and progressive tumorigenesis of human bronchial epithelial cell lines. Cancer Genet. Cytogenet., 1996, 92, 99-110.
275. Liu, F-J.; Barchowsky, A.; Opresko, P. L. The Werner syndrome protein functions in repair of Cr (VI)-induced replication-associated DNA damage. Toxicol. Sci., 2009, 110, 307-318
276. Bardales, R. H.; Xie, S. S.; Schaefer, R. F.; Hsu, S. M. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am. J. Pathol., 1996, 149, 845-852.
277. Kumar. P.; Goldstraw, P.; Yamada, K.; Nicholson, A. G.; Wells, A. U.; Hansell, D. M.; Dubois, R. M.; Ladas, G. Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. J. Thorac. Cardiovasc. Surg., 2003, 125, 1321-1327.
278. Higenbottam, T.; Kuwano, K.; Nemery, B.; Fujita, Y. Understanding the mechanisms of drug-associated interstitial lung disease. Br. J. Cancer, 2004, 91, S31-S37.
279. Brown, J. M.; Attardi, L. D. The role of apoptosis in cancer development and treatment response. Nat. Rev. Cancer, 2005, 5, 231-237.
280. Andrew, A. S.; Warren, A. J; Barchowsky, A.; Temple, K. A.; Klei, L.; Soucy, N. V.; O'Hara, K. A.; Hamilton, J. W. Genomic and proteomic profiling of responses to toxic metals in human lung cells. Environ. Health Perspect., 2003, 111, 825-835.
281. Ye, J.; Shi, X. Gene expression profile in response to chromiuminduced cell stress in A549 cells. Mol. Cell. Biochem., 2001, 222, 189-197.
282. Castorina, A.; Tiralongo, A.; Cavallo, D.; Loreto, C.; Carnazza, M. L.; Iavicoli, S.; D'Agata, V. Expression profile of ErbB receptor's family in human alveolar type 2-like cell line A549 exposed to hexavalent chromium. Toxicol. In Vitro, 2008, 22, 541-547.
283. Ceryak, S.; Zingariello, C.; O'Brien, T.; Patierno, S. R. Induction of pro-apoptotic and cell cycle-inhibiting genes in chromium (VI) - treated human lung fibroblasts: lack of effect of ERK. Mol. Cell. Biochem., 2004, 255, 139-149.
284. Dubrovskaya, V. A.; Wetterhahn, K. E. Effects of Cr (VI) on the expression of the oxidative stress genes in human lung cells. Carcinogenesis, 1998, 19, 1401-1407.
285. O'Hara, K. A.; Nemec, A. A.; Alam, J.; Klei, L. R.; Mossman, B. T.; Barchowsky, A. Chromium (VI) inhibits heme oxygenase-1 expression in vivo and in arsenic-exposed human airway epithelial cells. J. Cell. Physiol., 2006, 209, 113-121.
286. Gao, N; Jiang, B. H.; Leonard, S. S.; Corum, L.; Zhang, Z.; Roberts, J. R.; Antonini, J.; Zheng, J. Z.; Flynn, D. C.; Castranova, V.; Shi, X. p38 Signaling-mediated hypoxia-inducible factor 1α and vascular endothelial growth factor induction by Cr (VI) in DU145 human prostate carcinoma cells. J. Biol. Chem., 2002, 277, 45041-45048.
287. Hamilton, J. W.; Kaltreider, R. C.; Bajenova, O. V.; Ihnat, M. A.; McCaffrey, J.; Turpie, B. W.; Rowell, E. E.; Oh, J.; Nemeth, M. J.; Pesce, C. A.; Lariviere, J. P. Molecular basis for effects of carcinogenic heavy metals on inducible gene expression. Environ. Health Perspect., 1998, 106, 1005-1015.
288. Nemec, A. A.; Barchowsky, A. Signal transducer and activator of transcription 1 (STAT1) is essential for chromium silencing of gene induction in human airway epithelial cells. Toxicol. Sci., 2009, 110, 212-223.
289. Wetterhahn, K. E., Hamilton, J. W. Molecular basis of hexavalent chromium carcinogenicity: effect on gene expression. Sci. Total Environ., 1989, 86, 113-129.
290. Shumilla, J. A.; Broderick, R. J.; Wang, Y.; Barchowsky, A. Chromium (VI) inhibits the transcriptional activity of nuclear factor-κB by decreasing the interaction of p65 with cAMP-responsive elementbinding protein-binding protein. J. Biol. Chem., 1999, 274, 36207-36212.
291. Majumder, S.; Ghoshal, K.; Summers, D.; Bai, S.; Datta, J.; Jacob S. T. Chromium (VI) down-regulates heavy metal-induced metallothionein gene transcription by modifying transactivation potential of the key transcription factor, metal-responsive transcription factor 1. J. Biol. Chem., 2003, 278, 26216-26226.
292. Wei, Y. D., Tepperman, K., Huang, M. Y., Sartor, M. A., Puga, A. Chromium inhibits transcription from polycyclic aromatic hydrocarboninducible promoters by blocking the release of histone deacetylase and preventing the binding of p300 to chromatin. J. Biol. Chem., 2004, 279, 4110-4119.
293. O'Hara, K. A.; Vaghjiani, R. J.; Nemec, A. A.; Klei, L. R.; Barchowsky, A. Cr (VI)-stimulated STAT3 tyrosine phosphorylation and nuclear translocation in human airway epithelial cells requires Lck. Biochem. J., 2007, 402, 261-269.
294. Ye, J.; Wang, S.; Leonard, S. S.; Sun, Y.; Butterworth, L.; Antonini, J.; Ding, M.; Rojanasakul, Y.; Vallyathan, V.; Castranova, V.; Shi, X. Role of reactive oxygen species and p53 in chromium (VI) - induced apoptosis. J. Biol. Chem., 1999, 274, 34974-34980.
295. Wang, S., Shi, X. Mechanisms of Cr (VI)-induced p53 activation: the role of phosphorylation, mdm2 and ERK. Carcinogenesis, 2001, 22, 757-762.
296. Chen, F.; Bower, J.; Leonard, S. S.; Ding, M.; Lu, Y.; Rojanasakul, Y.; Kung, H. F.; Vallyathan, V.; Castranova, V.; Shi, X. Protective roles of NF-κB for chromium (VI)-induced cytotoxicity is revealed by expression of IκB kinase-β mutant. J. Biol. Chem., 2002, 277, 3342-3349.
297. Darnell Jr, J. E.; Kerr, I. M.; Stark, G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science, 1994, 264, 1415-1421.
298. Gimeno, R.; Lee, C. K.; Schindler, C.; Levy, D. E. Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by alpha/beta interferon in T lymphocytes. Mol. Cell Biol., 2005, 25, 5456-5465.
299. Tanabe, Y., Nishibori, T., Su, L., Arduini, R. M., Baker, D. P., David, M. Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes. J. Immunol., 2005, 174, 609-613.
300. Battle, T. E.; Lynch, R. A.; Frank, D. A. Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis. Cancer Res., 2006, 66, 3649-3657.
301. Huang, S.; Bucana, C. D.; Van Arsdall, M.; Fidler, I. J. Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells. Oncogene, 2002, 21, 2504-2512.
302. Xi, S.; Zhang, Q.; Gooding, W. E.; Smithgall, T. E.; Grandis, J. R. Constitutive activation of Stat5b contributes to carcinogenesis in vivo. Cancer Res., 2003, 63, 6763-6771.
303. Shornick, L. P.; Wells, A. G.; Zhang, Y.; Patel, A. C.; Huang, G.; Takami, K.; Sosa, M.; Shukla, N. A.; Agapov, E.; Holtzman, M. J. Airway epithelial versus immune cell Stat1 function for innate defense against respiratory viral infection. J. Immunol., 2008, 180, 3319-3328.
304. Walters, D. M., Antao-Menezes, A., Ingram, J. L., Rice, A. B., Nyska, A., Tani, Y., Kleeberger, S. R., Bonner, J. C. Susceptibility of signal transducer and activator of transcription-1-deficient mice to pulmonary fibrogenesis. Am. J. Pathol., 2005, 167, 1221-1229.
305. Antao-Menezes, A.; Turpin, E. A.; Bost, P. C.; Ryman-Rasmussen, J. P.; Bonner, J. C. STAT-1 signaling in human lung fibroblasts is induced by vanadium pentoxide through an IFN-beta autocrine loop. J. Immunol., 2008, 180, 4200-4207.
306. Nemec, A. A.; Zubritsky, L. M.; Barchowsky, A. Chromium (VI) stimulates Fyn to initiate innate immune gene induction in human airway epithelial cells. Chem. Res. Toxicol., 2010, 23, 396-404.
307. Boussat, S.; Eddahibi, S.; Coste, A.; Fataccioli, V.; Gouge, M.; Housset, B.; Adnot, S.; Maitre, B. Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol., 2000, 279, L371-L378.
308. Roberts, J. R.; Perkins, G. D.; Fujisawa, T.; Pettigrew, K. A.; Gao, F.; Ahmed, A.; Thickett, D. R. Vascular endothelial growth factor promotes physical wound repair and is anti-apoptotic in primary distal lung epithelial and A549 cells. Crit. Care Med., 2007, 35, 2164-2170.
309. Namiki, A.; Brogi, E.; Kearney, M.; Kim, E. A.; Wu, T.; Couffinhal, T.; Varticovski, L.; Isner, J. M. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J. Biol. Chem., 1995, 270, 31189-31195.
310. Semenza, G. L. HIF-1: upstream and downstream of cancer metabolism. Curr. Opin. Genet. Dev., 2010, 20, 51-56.
311. Coussens, L. M.; Werb, Z. Inflammation and cancer. Nature, 2002, 420, 860-867.
312. Xu, J.; Manning, F. C.; Patierno, S. R. Preferential formation and repair of chromium-induced DNA adducts and DNA-protein crosslinks in nuclear matrix DNA. Carcinogenesis, 1994, 15, 1443-1450.
313. Maier, A.; Dalton, T. P.; Puga, A. Disruption of dioxin-inducible phase I and phase II gene expression patterns by cadmium, chromium, and arsenic. Mol. Carcinog., 2000, 28, 225-235.
314. Schnekenburger, M.; Talaska, G.; Puga, A. Chromium cross-links histone deacetylase 1-DNA methyltransferase 1 complexes to chromatin, inhibiting histone-remodeling marks critical for transcriptional activation. Mol. Cell Biol., 2007, 27, 7089-7101.
315. Shumilla, J. A.; Wetterhahn, K. E.; Barchowsky, A. Inhibition of NF-kappa B binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism. Arch. Biochem. Biophys., 1998, 349, 356-362.
316. Klampfer, L.; Huang, J.; Swaby, L. A.; Augenlicht, L. Requirement of histone deacetylase activity for signaling by STAT1. J. Biol. Chem., 2004, 279, 30358-30368.
317. Sakamoto, S.; Potla, R.; Larner, A. C. Histone deacetylase activity is required to recruit RNA polymerase II to the promoters of selected interferon-stimulated early response genes. J. Biol. Chem., 2004, 279, 40362-40367.
318. Hamilton, J. W.; Wetterhahn, K. E. Differential effects of chromium (VI) on constitutive and inducible gene expression in chick embryo liver in vivo and correlation with chromium (VI)-induced DNA damage. Mol. Carcinog., 1989, 2, 274-286.
319. McCaffrey, J.; Wolf, C. M.; Hamilton, J. W. Effects of the genotoxic carcinogen chromium (VI) on basal and hormone-inducible phosphoenolpyruvate carboxykinase gene expression in vivo: correlation with glucocorticoid-and developmentally regulated expression. Mol. Carcinog., 1994, 10, 189-198.
320. Manning, F. C.; Xu, J.; Patierno, S. R. Transcriptional inhibition by carcinogenic chromate: relationship to DNA damage. Mol. Carcinog., 1992, 6, 270-279.
321. Hollstein, M.; Sidransky, B.; Vogelstein, B.; Harris, C. C. p53 mutations in human cancers. Science, 1991, 253, 5015, 49-53.
322. Hayashi, Y.; Kondo, T.; Zao, Q.; Ogawa, R.; Cui, Z.; Feril Jr., L. B.; Teranishi, H.; Kasuya, M. Signal transduction of p53-independent apoptotic pathway induced by hexavalent chromium in U937 cells. Toxicol. Appl. Pharmacol., 2004, 197, 96-106.
323. Cadet, J.; Berger, M.; Douki, T.; Ravanat, J. L. Oxidative damage to DNA: formation, measurement, and biological significance. Rev. Physiol. Biochem. Pharmacol., 1997, 131, 1-87.
324. Hussain, S. P.; Hofseth, L. J.; Harris, C. C. Radical causes of cancer. Nat. Rev. Cancer, 2003, 3, 276-285.
325. Hazzalin, C. A.; Mahadevan, L. C. MAPK-regulated transcription: a continuously variable gene switch? Nat. Rev. Mol. Cell Biol., 2002, 3, 30-40.
326. Raman, M.; Chen, W.; Cobb, M. H. Differential regulation and properties of MAPKs. Oncogene, 2007, 26, 3100-3112.
327. Kim, G.; Yurkow, E. J. Chromium induces a persistent activation of mitogen-activated protein kinases by a redox-sensitive mechanism in H4 rat hepatoma cells. Cancer Res., 1996, 56, 2045-2051.
328. O'Hara, K. A.; Klei, L. R.; Barchowsky, A. Selective activation of Src family kinases and JNK by low levels of chromium (VI). Toxicol. Appl. Pharmacol., 2003, 190, 214-223.
329. Ye, J.; Zhang, X.; Young, H. A.; Mao, Y.; Shi, X. Chromium (VI) - induced nuclear factor-κB activation in intact cells via free radical reactions. Carcinogenesis, 1995, 16, 2401-2405.
330. Yurkow, E. J.; Kim, G. Effects of chromium on basal and insulininduced tyrosine phosphorylation in H4 hepatoma cells: comparison with phorbol-12-myristate-13-acetate and sodium orthovanadate. Mol. Pharmacol., 1995, 47, 686-695.
331. Nelson, D. L.; Cox, M. M. Lehninger Principles of Biochemistry; W. H. Freeman and Company: New York, 2008.
332. Bellacosa, A.; Testa, J. R.; Staal, S. P.; Tsichlis, P. N. A retroviral oncogene, Akt, encoding a serine-threonine kinase containing an SH2-like region. Science, 1991, 254, 274-277.
333. Altomare, D. A.; Testa, J. R. Perturbations of the AKT signaling pathway in human cancer. Oncogene, 2005, 24, 7455-7464.
334. Bae, D.; Camilli, T. C.; Chun, G.; Lal, M.; Wright, K.; O'Brien, T. J.; Patierno, S. R.; Ceryak, S. Bypass of hexavalent chromium-induced growth arrest by a protein tyrosine phosphatase inhibitor: enhanced survival and mutagenesis. Mutat. Res.-Fundam. Mol. Mech. Mutagen., 2009, 660, 40-66.
335. Lal, M. A.; Bae, D.; Camilli, T. C.; Patierno, S. R.; Ceryak, S. AKT1 mediates bypass of the G1/S checkpoint after genotoxic stress in normal human cells. Cell Cycle, 2009, 10, 1589-1602.
336. van Vugt, M. A.; Medema, R. H. Getting in and out of mitosis with Polo-like kinase-1. Oncogene, 2005, 24, 2844-2859.
337. Chun, G.; Bae, D.; Nickens, K.; O'Brien, T. J.; Patierno, S. R; Ceryak, S. Polo-like kinase 1 enhances survival and mutagenesis after genotoxic stress in normal cells through cell cycle checkpoint bypass. Carcinogenesis, 2010, 31, 785-793.
338. Bae, D.; Camilli, T. C.; Ha, N. T.; Ceryak, S. Enhanced clonogenic survival induced by protein tyrosine phosphatase (PTP) inhibition after Cr (VI) exposure is mediated by c-Raf and Ras activity. Cell. Signal., 2009, 21, 727-736.
339. Chuang, S. M.; Liou, G. Y.; Yang, J. L. Activation of JNK, p38 and ERK mitogenactivated protein kinases by chromium (VI) is mediated through oxidative stress but does not affect cytotoxicity. Carcinogenesis, 2000, 21, 1491-1500.
340. Chen, L.; Ovesen, J. L.; Puga, A.; Xia, Y. Distinct contributions of JNK and p38 to chromium cytotoxicity and inhibition of murine embryonic stem cell differentiation. Environ. Health Perspect., 2009, 117, 1124-1130.
341. Abraham, R. T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev., 2001, 15, 2177-2196.
342. Burma, S.; Chen, B. P.; Murphy, M.; Kurimasa, A.; Chen, D. J. ATM phosphorylates histone H2AX in response to DNA doublestrand breaks. J. Biol. Chem., 2001, 276, 42462-42467.
343. Ward, I. M.; Chen, J. Histone H2AX is phosphorylated in an ATRdependent manner in response to replicational stress. J. Biol. Chem., 2001, 276, 47759-47762.
344. Park, E. J.; Chan, D. W.; Park, J. H.; Oettinger, M. A.; Kwon, J. DNA-PK is activated by nucleosomes and phosphorylates H2AX within the nucleosomes in an acetylation-dependent manner. Nucleic Acids Res., 2003, 31, 6819-6827.
345. Shiloh, Y. ATM: from phenotype to functional genomics-and back. Ernst Schering Res. Found. Workshop, 2002, 51-70.
346. Mochan, T. A.; Venere, M.; Di Tullio Jr, R. A.; Halazonetis, T. D. 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage. Cancer Res., 2003, 63, 8586-8591.
347. Xie, H.; Wise, S. S.; Holmes, A. L.; Xu, B.; Wakeman, T. P.; Pelsue, S. C.; Singh, N. P.; Wise Sr, J. P. Carcinogenic lead chromate induces DNA double strand breaks in human lung cells. Mutat. Res. Genet. Toxicol. Environ. Mutagen., 2005, 586, 160-172.
348. Wang, B.; Matsuoka, S.; Carpenter, P. B.; Elledge, S. J. 53BP1, a mediator of the DNA damage checkpoint. Science, 2002, 298, 1435-1438.
349. Foe, J. R.; Rooimans, M. A.; Bosnoyan-Collins, L.; Alon, N.; Wijker, M.; Parker, L.; Lightfoot, J.; Carreau, M.; Callen, D. F.; Savoia, A.; Cheng, N. C.; van Berkel, C. G.; Strunk, M. H.; Gille, J. J.; Pals, G.; Kruyt, F. A.; Pronk, J. C.; Arwert, F.; Buchwald, M.; Joenje, H. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat. Genet., 1996, 14, 320-323.
350. de Winter, J. P.; Leveille, F.; van Berkel, C. G.; Rooimans, M. A.; van Der, W. L.; Steltenpool, J.; Demuth, I.; Morgan, N. V.; Alon, N.; Bosnoyan-Collins, L.; Lightfoot, J.; Leegwater, P. A.; Waisfisz, Q.; Komatsu, K.; Arwert, F.; Pronk, J. C.; Mathew, C. G.; Digweed, M.; Buchwald, M.; Joenje, H. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am. J. Hum. Genet., 2000, 67, 1306-1308.
351. de Winter, J. P.; van der Weel, L.; de Groot, J.; Stone, S.; Waisfisz, Q.; Arwert, F.; Scheper, R. J.; Kruyt, F. A.; Hoatlin, M. E.; Joenje, H. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum. Mol. Genet., 2000, 9, 2665-2674.
352. Timmers, C.; Taniguchi, T.; Hejna, J.; Reifsteck, C.; Lucas, L.; Bruun, D.; Thayer, M.; Cox, B.; Olson, S.; D'Andrea, A. D.; Moses, R.; Grompe, M. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol. Cell, 2001, 7, 241-248.
353. Li, X.; Heyer, W. D. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res., 2008, 18, 99-113.
354. Taniguchi, T.; Garcia-Higuera, I.; Andreassen, P. R.; Gregory, R. C.; Grompe, M.; D'Andrea, A. D. S-phase specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood, 2002, 100, 2414-2420.
355. Kennedy, R. D.; D'Andrea, A. D. The Fanconi Anemia/BRCA pathway: new faces in the crowd. Genes Dev., 2005, 19, 2925-2940.
356. Moynahan, M. E.; Pierce, A. J.; Jasin, M. BRCA2 is required for homology-directed repair of chromosomal breaks. Mol. Cell, 2001, 7, 263-272.
357. Fujiwara, Y. Defective repair of mitomycin C crosslinks in Fanconi's anemia and loss in confluent normal human and xeroderma pigmentosum cells. Biochim. Biophys. Acta, 1982, 699, 217-225.
358. Rey, J. P.; Scott, R.; Muller, H. Induction and removal of interstrand crosslinks in the ribosomal RNA genes of lymphoblastoid cell lines from patients with Fanconi anemia. Mutat. Res., 1993, 289, 171-180.
359. Rosselli, F.; Briot, D.; Pichierri, P. The Fanconi anemia pathway and the DNA interstrand cross-links repair. Biochimie, 2003, 85, 1175-1184.
360. Vilcheck, S. K.; O'Brien, T. J.; Pritchard, D. E.; Ha, L.; Ceryak, S.; Fornsaglio, J. L.; Patierno, S. R. Fanconi anemia complementation group A cells are hypersensitive to chromium (VI)-induced toxicity. Environ. Health Perspect., 2002, 110, 773-777.
361. Vilcheck, S. K.; Ceryak, S.; O'Brien, T. J.; Patierno, S. R. FANCD2 monoubiquitination and activation by hexavalent chromium [Cr (VI)] exposure: activation is not required for repair of Cr (VI)-induced DSBs. Mutat. Res. Genet. Toxicol. Environ. Mutagen., 2006, 610, 21-30.
362. Yamamoto, K.; Hirano, S.; Ishiai, M.; Morishima, K.; Kitao, H.; Namikoshi, K.; Kimura, M.; Matsushita, N.; Arakawa, H.; Buerstedde, J. M.; Komatsu, K.; Thompson, L. H.; Takata, M. Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination. Mol. Cell Biol., 2005, 25, 34-43
363. Bryant, H. E.; Ying, S.; Helleday, T. Homologous recombination is involved in repair of chromium-induced DNA damage in mammalian cells. Mutat. Res. Fundam. Mol. Mech. Mutagen., 2006, 599, 116-123.
364. Stackpole, M. M.; Wise, S. S.; Goodale, B. C.; Duzevika, E. G.; Munroe, R. C.; Thompson, W. D.; Thackerd, J.; Thompsone, L. H.; Hinze, J. M.; Wise Sr, J. P. Homologous recombination repair protects against particulate chromate-induced chromosome instability in Chinese hamster cells. Mutat. Res. Fundam. Mol. Mech. Mutagen., 2007, 625, 145-154.
365. Camrye, E.; Wise, S. S.; Milligan, P.; Gordon, N.; Goodale, B.; Stackpole, M.; Patzlaff, N.; Aboueissa, A.; Sr Wise, J. P. Ku80 deficiency does not affect particulate chromate-induced chromosome damage and cytotoxicity in Chinese hamster ovary cells. Toxicol. Sci., 2007, 97, 348-354.
366. Savery, L. C.; Grlickova-Duzevick, E.; Wise, S. S.; Thompson, W. D.; Hinz, J. M.; Thompson, L. H.; Wise Sr, J. P. Role of the Fancg gene in protecting cells from particulate chromate-induced chromosome instability. Mutat. Res. Genet. Toxicol. Environ. Mutagen., 2007, 626, 120-127.
367. van den Bosch, M.; Lohman, P. H.; Pastink, A. DNA double-strand break repair by homologous recombination. Biol. Chem., 2002, 383, 873-892.
368. Ferreira, M. G.; Cooper, J. P. Two modes of DNA double-strand break repair are reciprocally regulated through the fission yeast cell cycle. Genes Dev., 2004, 18, 2249-2254.
369. Fabarius, A.; Hehlmann, R.; Duesberg, P. H. Instability of chromosome structure in cancer cells increases exponentially with degrees of aneuploidy. Cancer Genet. Cytogenet., 2003, 143, 59-72.
370. Cohen, M. D.; Zelikoff, J. T.; Chen, L. C.; Schlesinger, R. B. Immunotoxicologic effects of inhaled chromium: role of particle solubility and co-exposure to ozone. Toxicol. Appl. Pharmacol., 1998, 152, 30-40.
371. Kim, H. Y.; Lee, S. B.; Jang, B. S. Subchronic inhalation toxicity of soluble hexavalent chromium trioxide in rats. Arch. Toxicol., 2004, 78, 363-368.
372. Nicholson, A. G.; Wotherspoon, A. C.; Diss, T. C.; Hansell, D. M.; Du Bois, R.; Sheppard, M. N.; Isaacson, P. G.; Corrin, B. Reactive pulmonary lymphoid disorders. Histopathol., 1995, 26, 405-412.
373. Suda, T.; Chida, K.; Hayakawa, H.; Imokawa, S.; Iwata, M.; Nakamura, H.; Sato, A. Development of bronchus-associated lymphoid tissue in chronic hypersensitivity pneumonitis. Chest, 1999, 115, 357-363.
374. Balansky, R. M.; D'Agostini, F.; De Flora, S. Induction, persistence and modulation of cytogenetic alterations in cells of smoke-exposed mice. Carcinogenesis, 1999, 20, 1491-1497.
375. Santillan, A. A.; Camargo Jr, C. A.; Colditz, G. A. A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control, 2003, 14, 327-334.
376. Yang, P.; Bamlet, W. R.; Sun, Z.; Ebbert, J. O.; Aubry, M. C.; Krowka, M. J.; Taylor, W. R.; Marks, R. S.; Deschamps, C.; Swensen, S. J.; Wieben, E. D.; Cunningham, J. M.; Melton, L. J.; de Andrade, M. Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk. Chest, 2005, 128, 445-452.
377. Turner, M. C.; Chen, Y.; Krewski, D.; Calle, E. E.; Thun, M. J. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am. J. Respir. Crit. Care Med., 2007, 176, 285-290.
378. Albini, A.; Sporn, M. B. The tumour microenvironment as a target for chemoprevention. Nat. Rev. Cancer, 2007, 7, 139-147.
379. Khuder, S. A.; Herial, N. A.; Mutgi, A. B.; Federman, D. J. Nonsteroidal antiinflammatory drug use and lung cancer: a metaanalysis. Chest, 2005, 127, 748-754.
380. Van Dyke, A. L.; Cote, M. L.; Prysak, G.; Claeys, G. B.; Wenzlaff, A. S.; Schwartz, A. G. Regular adult aspirin use decreases the risk of non-small cell lung cancer among women. Cancer Epidemiol. Biomark. Prev., 2008, 17, 148-157.
381. Federico, A.; Morgillo, F.; Tuccillo, C.; Ciardiello, F.; Loguercio, C. Chronic inflammation and oxidative stress in human carcinogenesis. Int. J. Cancer, 2007, 121, 2381-2386.
382. Chapman, S. J.; Cookson, W. O.; Musk, A. W.; Lee, Y. C. Benign asbestos pleural diseases. Curr. Opin. Pulm. Med., 2003, 9, 266-271.
383. Taylor, M. D.; Roberts, J. R.; Leonard, S. S.; Shi, X.; Antonini, J. M. Effects of welding fumes of differing composition and solubility on free radical production and acute lung injury and inflammation in rats. Toxicol. Sci., 2003, 75, 181-191.
384. Solano-Lopez, C.; Zeidler-Erdely, P. C.; Hubbs, A. F.; Reynolds, S. H.; Roberts, J. R.; Taylor, M. D.; Young, S.; Castranova, V.; Antonini, J. M. Welding fume exposure and associated inflammatory and hyperplastic changes in the lungs of tumor susceptible A/J mice. Toxicol. Pathol., 2006, 34, 364-372.
385. Antonini, J. M.; Stone, S.; Roberts, J. R.; Chen, B.; Schwegler-Berry, D.; Afshari, A. A.; Frazer, D. G. Effect of short-term stainless steel welding fume inhalation exposure on lung inflammation, injury, and defense responses in rats. Toxicol. Appl. Pharmacol., 2007, 223, 234-245.
386. Zeidler-Erdely, P. C.; Kashon, M. L.; Battelli, L. A.; Young, S. H.; Erdely, A.; Roberts, J. R.; Reynolds, S. H.; Antonini, J. M. Pulmonary inflammation and tumor induction in lung tumor susceptible A/J and resistant C57BL/6J mice exposed to welding fume. Part. Fibre Toxicol., 2008, 5-12.
387. Eming, S. A.; Krieg, T.; Davidson, J. M. Inflammation in wound repair: molecular and cellular mechanisms. J. Invest, Dermatol., 2007, 127, 514-525.
388. Kim, J. H.; Suk, M. H.; Yoon, D. W.; Lee, S. H.; Hur, G. Y.; Jung, K. H.; Jeong, H. C.; Lee, S. Y.; Lee, S. Y.; Suh, I. B.; Shin, C.; Shim, J. J.; In, K. H.; Yoo, S. H.; Kang, K. H. Inhibition of matrix metalloproteinase-9 prevents neutrophilic inflammation in ventilator-induced lung injury. Am. J. Physiol. Lung Cell Mol. Physiol., 2006, 291, L580-L587.
389. Warburg, O. Tests on surviving carcinoma cultures. Biochem. Z., 1923, 142, 317-333.
390. Pauwels, E. K. J.; Sturm, E. J. C.; Bombardieri, E.; Cleton, F. J.; Stokkel, M. P. M. Positron-emission tomography with [F-18]fluorodeoxyglucose Part I. Biochemical uptake mechanism and its implication for clinical studies. J. Cancer Res. Clin. Oncol., 2000, 126, 549-559.
391. Debetto, P.; Luciani, S. Toxic effect of chromium on cellular metabolism. Sci. Total Environ., 1988, 71, 365-377.
392. Carter, C. E. Metabolism of purines and pyrimidines. Ann. Rev. Biochem., 1956, 25, 123-146.
393. Gonçalves, M. J.; Santos, A. C. C.; Rodrigues, C. F. D.; Coelho, P; Costa, A. N.; Guiomar, A. J.; Santos, M. S.; Alpoim, M. C.; Urbano, A. M. Changes in glucose uptake rate and in the energy status of PC-12 cells acutely exposed to hexavalent chromium, an established human carcinogen. Toxicol. Environm. Chem., 2011, 93, 1202-1211.